Ginkgo Bioworks Hldgs Inc (DNA)
$0.28
0.00 (0.00%)
DNA Stock Quote Delayed 30 Minutes
Why Is Ginkgo Bioworks (DNA) Stock in the Spotlight Today?
DNA stock is down even while Ginkgo Bioworks prepares to purchase a biotech business and a large research and development site.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
18,777
Day's Range
-
52-Week Range
$0.26 - $2.54
Dividend & Yield
N/A (N/A)
DNA Stock Predictions, Articles, and Ginkgo Bioworks Hldgs Inc News
Billionaire Andreas Halvorsen Just Bought DNA Stock. Here’s Why.
DNA stock is surging higher today following large purchases from Viking Global's Andreas Halvorsen and Ark Invest's Cathie Wood.
Cathie Wood Is Making a Big Bet on Gingko Bioworks (DNA) Stock
Cathie Wood's Ark Invest has purchased more than 3.5 million shares of DNA stock since June 29, its first purchases in over a month.
Cathie Wood Keeps Buying Gingko Bioworks (DNA) Stock
Shares of DNA stock are in focus following Ark Invest's buying spree this month. In the past two days, Ark has purchased 4.5 million shares.
Losing Money Is in Ginkgo Bioworks Holdings’ DNA
DNA stock is a falling knife in 2022, and the latest earnings do not justify being optimistic about reaching profitability soon.
Cathie Wood Keeps Buying Gingko Bioworks (DNA) Stock. Here’s Why.
DNA stock is in the spotlight after Ark Invest reported purchasing more than 1.5 million shares this week. So, who else is betting big on Ginkgo?
Why Is Ginkgo Bioworks (DNA) Stock Up Today?
Biotechnology company Ginkgo Bioworks has a host of promising collaboration announcements. DNA stock is up as a result.
Baillie Gifford Just Bought Ginkgo Bioworks (DNA) Stock. Here’s Why.
Baillie Gifford recently disclosed that it purchased 48.8 million shares of DNA stock on March 31. The firm has a $180 billion portfolio.
Is DNA Stock a Buy After Earnings? 3 Analysts Weigh In on Gingko Bioworks.
DNA stock is bouncing higher following a better-than-expected earnings report and strong forward guidance from Gingko Bioworks.
Ginkgo Bioworks Price Predictions: Why One Analyst Thinks Hard-Hit DNA Stock Can Hit $14.50
Today, a bullish analyst price target placed on Ginkgo Bioworks has sent DNA stock on a nice ride as investors pile into this growth play.
DNA Stock: The Bull Call That Has Ginkgo Bioworks Bouncing Back After Last Week’s “Scam” Accusation
Ginkgo Bioworks (DNA) stock is doing well on Tuesday as it recovers with new coverage from an analyst with a bull stance.
DNA Stock: 7 Things to Know About the Short Report Hammering Ginkgo Bioworks
Today, Ginko Bioworks and DNA stock are firmly in the sights of short-sellers as various claims are made about an elaborate fraud underway.
SRNG, DNA: 14 Things to Know About Ginkgo Bioworks and the Soaring Eagle SPAC Merger
Ginkgo Bioworks (DNA) stock is set to start trading today as the company completes its merger with SPAC Soaring Eagle (SRNG).
